2,5-dimethoxy-4-bromoamphetamine has been researched along with 2,4,5-trimethoxyphenylisopropylamine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA; Liebowitz, SM; Mack, EC | 1 |
| Hall, LH; Kier, LB | 1 |
| Bartyzel, P; Glennon, RA; Leonhardt, S; Raghupathi, R; Teitler, M | 1 |
| Glennon, RA; Lyon, RA; Roth, BL; Seggel, MR; Suba, EA; Titeler, M; Yousif, MY | 1 |
| Glennon, RA | 2 |
| Benington, F; Glennon, RA; Morin, RD; Young, R | 1 |
| Anderson, GM; Castagnoli, N; Domelsmith, LN; Eaton, TA; Glennon, RA; Houk, KN; Kollman, PA; Shulgin, AT | 1 |
| Anderson, GM; Glennon, RA; Liebowitz, SM | 1 |
| Clare, BW | 1 |
| Glennon, RA; Peddi, S; Roth, BL; Westkaemper, RB | 1 |
| Glennon, RA; Mosier, PD; Roth, BL; Runyon, SP; Westkaemper, RB | 1 |
| Berg, KA; Cassels, BK; Clarke, WP; Gutiérrez-Hernandez, MA; Moya, PR; Reyes-Parada, M; Sáez-Briones, P | 1 |
| Ewald, AH; Maurer, HH | 1 |
1 review(s) available for 2,5-dimethoxy-4-bromoamphetamine and 2,4,5-trimethoxyphenylisopropylamine
| Article | Year |
|---|---|
Central serotonin receptors as targets for drug research.
Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin | 1987 |
13 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and 2,4,5-trimethoxyphenylisopropylamine
| Article | Year |
|---|---|
Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues.
Topics: Amines; Animals; Female; Hallucinogens; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; N,N-Dimethyltryptamine; Rats; Receptors, Serotonin; Stomach; Tryptamines | 1978 |
Structure-activity studies on hallucinogenic amphetamines using molecular connectivity.
Topics: Amphetamines; Chemical Phenomena; Chemistry, Physical; Hallucinogens; Models, Chemical; Structure-Activity Relationship | 1977 |
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
Topics: Animals; Binding Sites; Binding, Competitive; Ergolines; Ketanserin; Male; Molecular Structure; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Structure-Activity Relationship; Tritium | 1992 |
A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors.
Topics: Amphetamines; Animals; In Vitro Techniques; Ketanserin; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Solubility; Structure-Activity Relationship | 1990 |
Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
Topics: Amphetamines; Animals; Behavior, Animal; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; In Vitro Techniques; Isomerism; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1982 |
Photoelectron spectra of psychotropic drugs. 6. Relationships between the physical properties and pharmacological actions of amphetamine analogues.
Topics: Amphetamines; Animals; Chemical Phenomena; Chemistry, Physical; Humans; Psychotropic Drugs; Rabbits; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 1981 |
Serotonin receptor affinities of psychoactive phenalkylamine analogues.
Topics: Amines; Animals; Female; Hallucinogens; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Receptors, Serotonin; Stomach; Structure-Activity Relationship | 1980 |
The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
Topics: Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Phenethylamines; Quantum Theory | 1998 |
Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptor.
Topics: Cyclopentanes; Indicators and Reagents; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Serotonin Agents; Structure-Activity Relationship | 2003 |
Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
Topics: Animals; Anthracenes; Cattle; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis; Protein Binding; Receptor, Serotonin, 5-HT2A; Sequence Alignment; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship | 2008 |
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Topics: Amphetamines; Animals; Arachidonic Acid; Behavior, Animal; CHO Cells; Cricetinae; Cricetulus; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Humans; Inositol Phosphates; Male; Mescaline; Motor Activity; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Signal Transduction; Transfection | 2007 |
2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
Topics: Algorithms; Amphetamines; Animals; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Designer Drugs; DOM 2,5-Dimethoxy-4-Methylamphetamine; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Hydroxylation; Insecta; Kinetics; Microsomes, Liver; Molecular Structure; Quinidine; Spectrometry, Mass, Electrospray Ionization | 2008 |